Drug intelligence / Profile preview

bithionol sulfoxide

Development stage
Unknown
Modality
Small Molecules
Administration
Oral
01

Overview

Bithionol sulfoxide is an anthelmintic agent primarily utilized in veterinary medicine for the treatment of trematode infections, specifically liver flukes (*Fasciola* species) and rumen flukes (*Paramphistomum* species) in ruminants such as cattle, sheep, and goats. As a derivative of bithionol, it functions by uncoupling oxidative phosphorylation in the mitochondria of the parasites, thereby depleting their energy reserves and leading to paralysis and death. It is commonly formulated as an oral bolus for livestock. While the parent compound bithionol has been used in humans for paragonimiasis, the sulfoxide form is predominantly associated with veterinary applications and is manufactured as a generic formulation by companies such as Ambrosia Remedies.

Brand names
Bithionol Sulfoxide Bolus
Other names
bithionoloxidebithionol-S-oxidebis(2-hydroxy-3,5-dichlorophenyl) sulfoxide
02

Targets

AARS (Alanine–tRNA ligase)SecA1 (Protein translocase subunit SecA1)GyrA (DNA gyrase subunit A)Helminth mitochondrial electron transport chain (Helminth ETC)sAC (Soluble adenylyl cyclase)OXPHOS (Mitochondrial OXPHOS complexes)

Beyond the preview

Go deeper on bithionol sulfoxide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bithionol sulfoxide.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call